ARL-15896 inhibition of recombinant NMDA receptor calcium responses
Cell-based study · HEK cells expressing human NMDA receptor subtypes containing GluN2B or GluN2D [1]
The reference-antagonist comparison reports inhibition of agonist-evoked calcium responses. GluN2A was not determined for ARL-15896; the subtype results do not establish universal potency or a selective mechanism.
| Endpoint | Reported result | Reference |
|---|---|---|
| GluN2B-containing receptor calcium response | IC50 510,000 ± 240,000 nM (n = 3 replicate curves; mean IC50 ± SEM) | [1] |
| GluN2D-containing receptor calcium response | IC50 25,000 ± 8,000 nM (n = 3 replicate curves; mean IC50 ± SEM) | [1] |
Literature-Reported Treatment Conditions
- Treatment concentration
- Concentration-response series; individual ARL-15896 test concentrations not specified in Table 1. Agonists: glutamate and glycine, 3 μM each as reported.
- Exposure duration
- 10 min compound preincubation; 20 s fluorescence baseline and 3 min recording after agonist addition in the shared assay method.
- Method
- Fluo-8 calcium fluorescence, FDSS 6000; Hill-equation IC50 fitting using CDD Vault.
- Co-treatment
- Glutamate plus glycine stimulation; comparator antagonists were tested separately.
- Reported limits
- ARL test concentration series, exact salt/CAS, lot and ARL-specific solvent are not specified in the selected table/shared method. The detailed cell preparation describes GluN2A cells; subtype-specific preparation for B/D is not separately detailed there.
Methods and source locations
Compound reported in the paper: ARL-15896; Compound label in the paper: ARL-15896
Reported ARL-15896 assay evidence only; no salt conversion, stereochemical assay validation or Adooq lot validation.
Table 1 (ARL-15896 row, headings and footnote); Results opening paragraph; Materials and Methods: Reagents, Primary screening assays
GluN2B-containing receptor calcium response: Inhibition of glutamate/glycine-evoked calcium fluorescence; Hill fit. — Table 1, ARL-15896 row; column headings and footnote
GluN2D-containing receptor calcium response: Inhibition of glutamate/glycine-evoked calcium fluorescence; Hill fit. — Table 1, ARL-15896 row; column headings and footnote